Stockscreener 앱 받기
4.35
1.14%
-0.05
시장 영업 전:
4.77
0.42
+9.66%
Alumis Inc 주식(ALMS)의 최신 뉴스
Alumis Inc. sees $202,300 stock purchase by Foresite Capital - Investing.com
Alumis director James Tananbaum acquires $202,300 in stock By Investing.com - Investing.com Canada
Alumis director James Tananbaum acquires $202,300 in stock - Investing.com Australia
Alumis Inc. sees $202,300 in stock purchases by Foresite Labs - Investing.com
Alumis director Srinivas Akkaraju buys shares worth $1.48 million - Investing.com Australia
Alumis director Srinivas Akkaraju buys shares worth $1.48 million By Investing.com - Investing.com India
Leading Independent Proxy Advisory Firm ISS Recommends ACELYRIN Stockholders Vote 'FOR” the Proposed Transaction with Alumis - The Manila Times
Acelyrin urges stockholders to vote for proposed merger with Alumis - Yahoo Finance
ACELYRIN urges stockholders to approve Alumis merger - Investing.com
ACELYRIN Reiterates Benefits of Value-Maximizing Combination with Alumis - The Manila Times
ACELYRIN, Inc. Urges Stockholders to Vote in Favor of Proposed Merger with Alumis Inc. Ahead of May 13, 2025 Meeting - Nasdaq
ACELYRIN Board Makes Final Push for Alumis Merger: 48% Ownership Deal at Stake in Critical May Vote - Stock Titan
Confident Outlook on Acelyrin-Alumis Merger Amid Shareholder Opposition - TipRanks
Acelyrin gains as Trium Capital rebuffs M&A deal with Alumis - MSN
Acelyrin (SLRN) Faces Shareholder Opposition to Alumis Merger - GuruFocus
Acelyrin should liquidate instead of merging with Alumis, investor says - BioPharma Dive
Acelyrin stock gains as Trium rebuffs M&A deal (SLRN:NASDAQ) - Seeking Alpha
Alumis stock price target cut to $14 by H.C. Wainwright - Investing.com Australia
Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms - Endpoints News
Charles Schwab To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Revised merger terms boost ACELYRIN stake in Alumis deal By Investing.com - Investing.com South Africa
Alumis, ACELYRIN amend proposed merger pact - MSN
Alumis And Acelyrin Announce Amended Merger Agreement - marketscreener.com
Alumis Raises Share Consideration for Acelyrin Acquisition - marketscreener.com
ACELYRIN, INC. Amends Merger Agreement with Alumis - TipRanks
Revised merger terms boost ACELYRIN stake in Alumis deal - Investing.com
ACELYRIN and Alumis Announce Revised Merger Agreement Enhancing Stockholder Ownership and Value - Nasdaq
Alumis and ACELYRIN Announce Amended Merger Agreement - The Manila Times
Alumis Secures Major Immunology Merger: $737M Cash Runway Stretches to 2027, 62% Shareholders Back Deal - Stock Titan
ACELYRIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acelyrin, Inc.SLRN - MarketScreener
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday - Benzinga
3 Biopharmaceutical Stocks Bucking the Sell-Off - MarketBeat
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Alumis: Biotech's Stock Gains >100% In A MonthBut Risk Of Failure Is High (NASDAQ:ALMS) - Seeking Alpha
Top 3 Health Care Stocks That May Crash In Q2 - Benzinga
Alumis Reaches US$465m Market Cap Benefiting Insider Stock Buying - simplywall.st
Insider Buying: Alumis Independent Director Bought US$130k Of Shares - Yahoo
Alumis and ACELYRIN announce definitive merger plan By Investing.com - Investing.com South Africa
Alumis and ACELYRIN announce definitive merger plan - Investing.com Australia
Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger - The Manila Times
Major Biopharma Merger: Alumis and ACELYRIN Unite with $737M War Chest for Immune Disease Breakthroughs - Stock Titan
Simulations Plus Posts Better-Than-Expected Results, Joins Savers Value Village, MarketAxess Holdings And Other Big Stocks Moving Higher On Friday - Benzinga
Alumis Inc. CEO Martin Babler buys $100,732 in company stock By Investing.com - Investing.com Australia
Alumis Inc. director Alan Colowick buys $129,544 in stock By Investing.com - Investing.com Australia
5.24%
자본화:
|
볼륨(24시간):